New Study Demonstrates Clinical Validity of Lung Cancer Test EarlyCDT-Lung
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MoreSearch Results for: liver disease
BD Diagnostics Receives Moderate Complexity Status for the BD MAX GBS Assay
BD Diagnostics announced that it has received “Moderate Complexity” status from the FDA, under the Clinical Laboratory Improvement Amendments (CLIA), for the BD MAX GBS Assay for Group B Streptococcus(GBS).
Read More
The Business of Billing and Coding
Correct coding of lab tests is critical to reimbursement and profitability.
Read More
Shifting Standards in Respiratory Virus Diagnostics
Molecular diagnostics are replacing culture as the gold standard but continue to share the stage with conventional methods.
Read MoreRadient Pharmaceuticals Buying Provista Diagnostics
Radient Pharmaceuticals Corp (RPC) announced that it has entered into a letter of intent (LOI) to acquire Provista Diagnostics Inc (PDI), a Nevada corporation offering laboratory testing services that meet the Clinical Laboratory Improvement Act (CLIA) guidelines.
Read More